Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 0
Operating Income -20.6M
Net Income -21.1M
EPS (Diluted) -$0.31

Balance Sheet Metrics

Total Assets 84.4M
Total Liabilities 38.2M
Shareholders Equity 46.1M
Debt to Equity 0.83

Cash Flow Metrics

Operating Cash Flow -12.8M
Free Cash Flow -4.9M

Revenue & Profitability Trend

Citius Oncology Income Statement From 2022 to 2024

Metric202420232022
Revenue000
Cost of Goods Sold---
Gross Profit---
Operating Expenses20.6M12.1M4.9M
Operating Income-20.6M-12.1M-4.9M
Pre-tax Income-20.6M-12.1M-4.9M
Income Tax576.0K576.0K576.0K
Net Income-21.1M-12.7M-5.4M
EPS (Diluted)-$0.31-$0.18-$0.08

Income Statement Trend

Citius Oncology Balance Sheet From 2022 to 2024

Metric202420232022
Assets
Current Assets11.0M7.7M2.7M
Non-Current Assets73.4M40.0M40.0M
Total Assets84.4M47.7M42.7M
Liabilities
Current Liabilities32.7M21.0M5.8M
Non-Current Liabilities5.5M1.2M576.0K
Total Liabilities38.2M22.2M6.4M
Equity
Total Shareholders Equity46.1M25.5M36.3M

Balance Sheet Composition

Citius Oncology Cash Flow Statement From 2022 to 2024

Metric202420232022
Operating Activities
Net Income-21.1M-12.7M-5.4M
Operating Cash Flow-12.8M-9.0M-4.8M
Investing Activities
Capital Expenditures---
Investing Cash Flow---
Financing Activities
Dividends Paid---
Financing Cash Flow4.9M0-
Free Cash Flow-4.9M00

Cash Flow Trend

Citius Oncology Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -14.00
Price to Book 8.55
PEG Ratio -0.19

Profitability Ratios

Profit Margin 0.00%
Operating Margin 0.00%
Return on Equity -93.64%
Return on Assets -22.41%

Financial Health

Current Ratio 0.36
Debt to Equity 10.66
Beta -0.06

Per Share Data

EPS (TTM) -$0.38
Book Value per Share $0.50
Revenue per Share $0.00

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ctor304.8M-14.008.55-93.64%0.00%10.66
Zoetis 70.6B28.4515.1952.09%27.12%145.63
Haleon Plc - ADR 45.5B23.375.638.95%12.84%63.41
Indivior PLC 1.9B530.50-6.57-0.57%-5.30%-1.29
BioCryst 1.8B-21.07-4.1918.68%-10.62%-1.84
Supernus 1.8B28.911.776.32%9.27%3.13

Financial data is updated regularly. All figures are in the company's reporting currency.